The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Injectable Anticoagulants-Global Market Insights and Sales Trends 2025
Synopsis
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
The global Injectable Anticoagulants market size is expected to reach US$ 7058.3 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Anticoagulants in various end use industries. The expanding demands from the VTE, ACS/MI, AF and Others, are propelling Injectable Anticoagulants market. Low-Molecular-Weight Heparin (LMWH), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Direct Thrombin Inhibitor (DTI) segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.
North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Anticoagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Anticoagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Anticoagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Anticoagulants covered in this report include Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer, The Medicines Company, Aspen and Otsuka, etc.
The global Injectable Anticoagulants market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Global Injectable Anticoagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Anticoagulants market, Segment by Type:
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Global Injectable Anticoagulants market, by Application
VTE
ACS/MI
AF
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Injectable Anticoagulants companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
The global Injectable Anticoagulants market size is expected to reach US$ 7058.3 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Anticoagulants in various end use industries. The expanding demands from the VTE, ACS/MI, AF and Others, are propelling Injectable Anticoagulants market. Low-Molecular-Weight Heparin (LMWH), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Direct Thrombin Inhibitor (DTI) segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.
North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Anticoagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Anticoagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Anticoagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Anticoagulants covered in this report include Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer, The Medicines Company, Aspen and Otsuka, etc.
The global Injectable Anticoagulants market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Global Injectable Anticoagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Anticoagulants market, Segment by Type:
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Global Injectable Anticoagulants market, by Application
VTE
ACS/MI
AF
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Injectable Anticoagulants companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Injectable Anticoagulants
1.1 Injectable Anticoagulants Market Overview
1.1.1 Injectable Anticoagulants Product Scope
1.1.2 Injectable Anticoagulants Market Status and Outlook
1.2 Global Injectable Anticoagulants Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Injectable Anticoagulants Market Size by Region (2018-2029)
1.4 Global Injectable Anticoagulants Historic Market Size by Region (2018-2023)
1.5 Global Injectable Anticoagulants Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Injectable Anticoagulants Market Size (2018-2029)
1.6.1 North America Injectable Anticoagulants Market Size (2018-2029)
1.6.2 Europe Injectable Anticoagulants Market Size (2018-2029)
1.6.3 Asia-Pacific Injectable Anticoagulants Market Size (2018-2029)
1.6.4 Latin America Injectable Anticoagulants Market Size (2018-2029)
1.6.5 Middle East & Africa Injectable Anticoagulants Market Size (2018-2029)
2 Injectable Anticoagulants Market by Type
2.1 Introduction
2.1.1 Low-Molecular-Weight Heparin (LMWH)
2.1.2 Direct Thrombin Inhibitor (DTI)
2.1.3 Others
2.2 Global Injectable Anticoagulants Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Injectable Anticoagulants Historic Market Size by Type (2018-2023)
2.2.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Injectable Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Injectable Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Injectable Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Injectable Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Injectable Anticoagulants Revenue Breakdown by Type (2018-2029)
3 Injectable Anticoagulants Market Overview by Application
3.1 Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Injectable Anticoagulants Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Injectable Anticoagulants Historic Market Size by Application (2018-2023)
3.2.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Injectable Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Injectable Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Injectable Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Injectable Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Injectable Anticoagulants Revenue Breakdown by Application (2018-2029)
4 Injectable Anticoagulants Competition Analysis by Players
4.1 Global Injectable Anticoagulants Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2022)
4.3 Date of Key Players Enter into Injectable Anticoagulants Market
4.4 Global Top Players Injectable Anticoagulants Headquarters and Area Served
4.5 Key Players Injectable Anticoagulants Product Solution and Service
4.6 Competitive Status
4.6.1 Injectable Anticoagulants Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Injectable Anticoagulants Products, Services and Solutions
5.1.4 Sanofi Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Genentech (Roche)
5.2.1 Genentech (Roche) Profile
5.2.2 Genentech (Roche) Main Business
5.2.3 Genentech (Roche) Injectable Anticoagulants Products, Services and Solutions
5.2.4 Genentech (Roche) Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.2.5 Genentech (Roche) Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Injectable Anticoagulants Products, Services and Solutions
5.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Injectable Anticoagulants Products, Services and Solutions
5.4.4 Pfizer Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 The Medicines Company
5.5.1 The Medicines Company Profile
5.5.2 The Medicines Company Main Business
5.5.3 The Medicines Company Injectable Anticoagulants Products, Services and Solutions
5.5.4 The Medicines Company Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.5.5 The Medicines Company Recent Developments
5.6 Aspen
5.6.1 Aspen Profile
5.6.2 Aspen Main Business
5.6.3 Aspen Injectable Anticoagulants Products, Services and Solutions
5.6.4 Aspen Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.6.5 Aspen Recent Developments
5.7 Otsuka
5.7.1 Otsuka Profile
5.7.2 Otsuka Main Business
5.7.3 Otsuka Injectable Anticoagulants Products, Services and Solutions
5.7.4 Otsuka Injectable Anticoagulants Revenue (US$ Million) & (2018-2023)
5.7.5 Otsuka Recent Developments
6 North America
6.1 North America Injectable Anticoagulants Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Injectable Anticoagulants Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anticoagulants Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Injectable Anticoagulants Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Injectable Anticoagulants Market Dynamics
11.1 Injectable Anticoagulants Industry Trends
11.2 Injectable Anticoagulants Market Drivers
11.3 Injectable Anticoagulants Market Challenges
11.4 Injectable Anticoagulants Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
